
Drugmaker Piramal Healthcare raised 18 billion rupees through commercial papers with 30-day and 75-day maturities, to pay in part for raising its stake in Vodafone India unit, Rajesh Laddha, group chief financial officer told reuters on Monday.
Rs 17 crore: The jackpot in India Inc's salary sweepstakes
The firm said on Saturday it would buy a 5.5 percent stake in Vodafone's India unit from Essar for 30 billion rupees, taking its total stake in the mobile company to about 11 percent.
The firm paid a yield of 10.65 percent and 10.15 percent for the April and March maturity commercial paper transactions, respectively, which was arranged by Kotak Mahindra Bank.